Zai Lab (ZLAB) EBITDA Margin (2020 - 2026)

Zai Lab has disclosed EBITDA Margin across 7 years of filings, most recently posting 69.66% for Q1 2026.

• EBITDA Margin for Q1 2026 came in at 69.66%, up 665806.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5086.16% (up 494060.0% YoY), and the FY2025 annual result was 7647.8%, up 1250341.0% from the prior year.
• EBITDA Margin came in at 69.66% for Q1 2026 at Zai Lab, down from 21.06% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 197.43% in Q4 2023 to a low of 19016.0% in Q2 2024.
• The 5-year median for EBITDA Margin is 90.18% (2026), against an average of 1899.76%.
• Across the five-year window, EBITDA Margin sank 17383 bps in 2024 and soared 1896568 bps in 2025, its largest moves.
• Zai Lab's EBITDA Margin stood at 156.83% in 2022, then jumped by 226 bps to 197.43% in 2023, then sank by 88 bps to 23.6% in 2024, then decreased by 11 bps to 21.06% in 2025, then slumped by 431 bps to 69.66% in 2026.
• The last three EBITDA Margin figures came in at 69.66% (Q1 2026), 21.06% (Q4 2025), and 42.05% (Q3 2025), per Business Quant data.